湘泉药业 (836972.OC)

+ 收藏

现金流量表(湘泉药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 17,647,847.3629,820,435.6114,346,232.8081,222,577.6637,272,123.24
 收到的税费返还(元) -1,881.76-2,071,666.45-
 收到其他与经营活动有关的现金(元) 2,010,565.8129,834,313.072,689,624.3646,323,744.18686,600.96
 经营活动现金流入小计(元) 19,658,413.1759,656,630.4417,035,857.16129,617,988.2937,958,724.20
 购买商品、接受劳务支付的现金(元) 15,646,538.0231,805,655.9813,511,608.3368,367,702.7834,122,442.41
 支付给职工以及为职工支付的现金(元) 2,522,776.678,946,208.325,631,191.4310,041,760.983,784,911.40
 支付的各项税费(元) 1,817,719.896,223,594.883,542,950.792,895,102.93624,907.29
 支付其他与经营活动有关的现金(元) 11,917,541.0721,905,672.932,115,463.1230,707,460.204,452,113.18
 经营活动现金流出小计(元) 31,904,575.6568,881,132.1124,801,213.67112,012,026.8942,984,374.28
 经营活动产生的现金流量净额(元) -12,246,162.48-9,224,501.67-7,765,356.5117,605,961.40-5,025,650.08
二、投资活动产生的现金流量
 购建固定资产、无形资产和其他长期资产支付的现金(元) 175,469.91700,243.191,022,956.291,814,681.841,159,396.31
 投资活动现金流出小计(元) 175,469.91700,243.191,022,956.291,814,681.841,159,396.31
 投资活动产生的现金流量净额(元) -175,469.91-700,243.19-1,022,956.29-1,814,681.84-1,159,396.31
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 30,000,000.0081,970,000.0015,800,000.0097,300,000.0017,800,000.00
 收到其他与筹资活动有关的现金(元) -105,840,000.0060,000.00-7,000,000.00
 筹资活动现金流入小计(元) 30,000,000.00187,810,000.0015,860,000.0097,300,000.0024,800,000.00
 偿还债务支付的现金(元) 14,985,238.1097,642,857.1517,800,000.0099,300,000.0017,800,000.00
 分配股利、利润或偿付利息支付的现金(元) 3,354,292.194,011,768.532,171,480.9816,179,434.322,301,554.50
 支付其他与筹资活动有关的现金(元) -89,158,508.93---
 筹资活动现金流出小计(元) 18,339,530.29190,813,134.6119,971,480.98115,479,434.3220,101,554.50
 筹资活动产生的现金流量净额(元) 11,660,469.71-3,003,134.61-4,111,480.98-18,179,434.324,698,445.50
五、现金及现金等价物净增加额(元) -761,162.68-12,927,879.47-12,899,793.78-2,388,154.76-1,486,600.89
 加:期初现金及现金等价物余额(元) 913,633.9713,841,513.4413,841,513.4416,229,668.2016,229,668.20
 期末现金及现金等价物余额(元) 152,471.29913,633.97941,719.6613,841,513.4414,743,067.31
补充资料:
 净利润(元) -53,910.37-10,068,909.782,429,825.7211,090,354.486,361,428.56
 资产减值准备(元) 303,367.68638,844.96396,755.701,096,952.751,946,652.39
 固定资产和投资性房地产折旧(元) 2,310,864.764,524,289.152,270,110.494,466,711.232,224,583.44
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,310,864.764,524,289.152,270,110.494,466,711.232,224,583.44
 无形资产摊销(元) 35,640.00278,090.40139,045.20277,703.34138,658.14
 长期待摊费用摊销(元) -71,280.0035,640.0071,280.0035,640.00
 财务费用(元) 3,354,292.195,858,379.962,898,230.034,418,411.032,639,262.35
 递延所得税(元) -166,486.97-404,518.25-867,796.92-2,124,274.22-1,177,457.20
  其中:递延所得税资产减少(元) -166,486.97-404,518.25-867,796.92-2,124,274.22-1,177,457.20
 存货的减少(元) -7,027,367.64-8,680,027.65-13,223,823.39-15,629,835.73-5,262,002.04
 经营性应收项目的减少(元) -12,445,643.41-29,228,335.12-14,353,772.41-19,644,117.73-11,871,045.66
 经营性应付项目的增加(元) 808,655.6218,836,301.1110,752,393.5228,971,750.00-645,589.71
 现金的期末余额(元) 152,471.29913,633.97941,719.6613,841,513.4414,743,067.31
 减:现金的期初余额(元) 913,633.9713,841,513.4413,841,513.4416,229,668.2016,229,668.20
 现金及现金等价物的净增加额(元) -761,162.68-12,927,879.47-12,899,793.78-2,388,154.76-1,486,600.89
公告日期 2024-08-282024-04-302023-08-302023-04-262022-08-29
审计意见(境内) 保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院